Small Molecule Tyrosine Kinase Inhibitors of ErbB2/HER2/Neu in the Treatment of Aggressive Breast Cancer

By Schroeder Richard L.   Stevens Cheryl L.   Sridhar Jayalakshmi  

Molecules, Vol. 19, Iss. 9, 2014-09 ,pp. : 15196-15212

MDPI

Access to resources Recommend Favorite

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype

By Caggiari Laura   Miolo Gianmaria   Buonadonna Angela   Basile Debora   Santeufemia Davide A.   Cossu Antonio   Palmieri Giuseppe   De Zorzi Mariangela   Fornasarig Mara   Alessandrini Lara   Canzonieri Vincenzo   Lo Re Giovanni   Puglisi Fabio   Steffan Agostino   Cannizzaro Renato   De Re Valli  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2017-12 ,pp. : 47-47

MDPI

Access to resources Recommend Favorite

Pertuzumab Increases 17-AAG-Induced Degradation of ErbB2, and This Effect Is Further Increased by Combining Pertuzumab with Trastuzumab

By Hughes Juliana Bentes   Rødland Marianne Skeie   Hasmann Max   Madshus Inger Helene   Stang Espen  

Pharmaceuticals, Vol. 5, Iss. 7, 2012-06 ,pp. : 674-689

MDPI

Access to resources Recommend Favorite

Intrapleural Trastuzumab Therapy for Malignant Pleural Effusion from HER2 Overexpression in Metastatic Gastric Cancer

By  

Chemotherapy, Vol. 60, Iss. 5-6, 2015-0 ,pp. : 321-324

Karger

Access to resources Recommend Favorite

Evaluation of HER2 Gene Amplification in Breast Cancer Using Nuclei Microarray in Situ Hybridization

By Jiang Huiyong   Bai Xiaoyan   Zhang Cheng   Zhang Xuefeng  

International Journal of Molecular Sciences, Vol. 13, Iss. 5, 2012-05 ,pp. : 5519-5527

MDPI

Access to resources Recommend Favorite